Boston Scientific will purchase Ajax Health's Cortex and its OptiMap system to guide physicians performing AFib-treating ...

The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...

Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

Expanding its portfolio further into cardiovascular health, Marlborough medical device manufacturer Boston Scientific has ...

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...

As Boston Scientific’s pulsed field ablation business continues to grow, the medtech aims to nourish the program with the ...

The FDA has approved Johnson & Johnson's new tab device for a type of condition which causes abnormal heart rhythm, the company said on Thursday. The device, Varipulse, is a pulsed field ablation ...

Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...